Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2025)

Organogenesis Holdings has reported Change in Inventory over the past 8 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Change in Inventory at $3.0 million for Q4 2025, up 550.77% from a year ago — trailing twelve months through Dec 2025 was $17.9 million (up 188.77% YoY), and the annual figure for FY2025 was $17.9 million, up 188.77%.
  • Change in Inventory for Q4 2025 was $3.0 million at Organogenesis Holdings, up from -$938000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for ORGO hit a ceiling of $8.7 million in Q1 2025 and a floor of -$2.7 million in Q2 2024.
  • Median Change in Inventory over the past 5 years was $2.6 million (2023), compared with a mean of $2.6 million.
  • Biggest five-year swings in Change in Inventory: skyrocketed 2803.75% in 2023 and later crashed 241.39% in 2024.
  • Organogenesis Holdings' Change in Inventory stood at -$439000.0 in 2021, then soared by 584.74% to $2.1 million in 2022, then tumbled by 66.82% to $706000.0 in 2023, then plummeted by 35.55% to $455000.0 in 2024, then soared by 550.77% to $3.0 million in 2025.
  • The last three reported values for Change in Inventory were $3.0 million (Q4 2025), -$938000.0 (Q3 2025), and $7.2 million (Q2 2025) per Business Quant data.